VIKRAM SHUKLA: Open Payments
NPI 1275599649 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,101 in 39 payments from 10 companies in 2025. Trend: 2023 $611 · 2024 $700 · 2025 $1,101
Food & beverage: $1,101
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $298 |
| Neurocrine BioSciences, Inc. | 11 | $231 |
| Axsome Therapeutics, Inc. | 5 | $195 |
| Alkermes, Inc. | 5 | $134 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| Janssen Pharmaceuticals, Inc | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $32 |
| Noven Therapeutics, LLC | 1 | $18 |
| Almatica Pharma LLC | 1 | $15 |
Products named: CAPLYTA, INGREZZA, Auvelity, ARISTADA, COBENFY, INVEGA SUSTENNA, AUSTEDO XR, VRAYLAR.
Industry payments across NC — which companies pay providers there.
